Tag: Viruses
HIV Status Does Not Affect Outcomes of Tecovirimat Treatment for Mpox
No difference seen in treatment outcomes, including days to improvement, rate of persistent symptoms for those with, without HIV
CDC Reports No New Mpox Cases in Over a Week for First Time Since...
Since the outbreak began last May, more than 30,000 people have been infected with the virus and 42 people have died
Incidence of Mpox Higher for Most Racial, Ethnic-Minority Groups
Vaccination-to-case ratio was lower for Black and Hispanic versus White men during full analytic period
RSVpreF Safe, Effective for Preventing Respiratory Syncytial Virus Illness in Seniors
Findings seen in phase 3 trial of adults aged 60 years and older receiving a single intramuscular injection of RSVpreF vaccine
CDC Issues Warning as Two African Countries Fight Spread of Marburg Virus
14 cases identified in Equatorial Guinea, 10 of which were fatal; five people have died in eight confirmed cases in Tanzania
RSVpreF Vaccine Found to Be Safe, Effective During Pregnancy
Phase 3 trial shows the vaccine is effective against medically attended severe RSV-associated lower respiratory tract illness in infants
Pandemic Disrupted Respiratory Syncytial Virus Season Timing
However, evidence shows the 2022 to 2023 season is a return toward prepandemic seasonality
TikTok Videos on Mpox Are of Low Quality
Researchers say their findings highlights the risks of referring to TikTok or social media as health information source
Clinical Treatment Considerations Presented for Severe Mpox
Data were synthesized from animal models, medical countermeasure use for human cases of related OPXV, input from experts, experience during consultations
Single Dose of RSV Vaccine Prevents Acute Respiratory Infection in Seniors
High vaccine efficacy seen against RSV A and B subtypes, across age groups among those aged 60 years and older, and for those with coexisting conditions
